Brain Stroke

2

Review clinical trials related to Brain Stroke. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis

The study objective is to establish the safety and efficacy of endovascular adjunct stenting for patients undergoing mechanical thrombectomy (MT) that are found to have residual stenosis (70-99%) following attempted clot retrieval with either aspiration catheters or stent retrievers, per device instructions for use and device labeling.

Participants needed: 342
Trial details
Phase: Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: ProMedica Health SystemUpdated: May 22, 2026Locations: 1
Eligibility criteria

18 to 80 years of age [+10]

Females who are pregnant, or those of child-bearing potential with positive urin... [+15]

Status: Recruiting

Residual Stenosis and Restenosis Following Carotid Endarterectomy With Primary Closure, A Prospective Tracking Study

This prospective, multicenter observational study aims to evaluate the incidence, timing, and characteristics of residual and recurrent (restenosis) carotid artery stenosis following carotid endarterectomy (CEA) with primary closure. Conducted across several neurosurgical centers in the Czech Republic, the study will include patients undergoing elective CEA who meet standard clinical indications. Participants will undergo preoperative CT angiography and follow-up imaging at 30 days and 1 year post-surgery. Residual stenosis is defined as ≥50% luminal narrowing detected within 30 days postoperatively, while restenosis is evaluated at later time points. The study will also assess clinical outcomes such as ischemic stroke, TIA, myocardial infarction, and mortality. The standardized surgical technique and harmonized diagnostic algorithm across all centers aim to provide robust data on the performance and durability of primary closure CEA.

Participants needed: 300
Trial details
Age: 18-90Biological sex: AllType: ObservationalSponsor: Charles University, Czech RepublicUpdated: Jul 9, 2025Locations: 1Duration: 1 Year
Eligibility criteria

Not listed